- Home
- LSAK vs PSTX Comparison
LSAK vs PSTX Comparison
Compare LSAK & PSTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSAK
- PSTX
- Stock Information
- Founded
- LSAK 1997
- PSTX 2014
- Country
- LSAK South Africa
- PSTX United States
- Employees
- LSAK N/A
- PSTX N/A
- Industry
- LSAK Investment Bankers/Brokers/Service
- PSTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LSAK Finance
- PSTX Health Care
- Exchange
- LSAK Nasdaq
- PSTX Nasdaq
- Market Cap
- LSAK N/A
- PSTX 249.1M
- IPO Year
- LSAK N/A
- PSTX 2020
- Fundamental
- Price
- LSAK $5.10
- PSTX $2.50
- Analyst Decision
- LSAK
- PSTX Strong Buy
- Analyst Count
- LSAK 0
- PSTX 2
- Target Price
- LSAK N/A
- PSTX $15.00
- AVG Volume (30 Days)
- LSAK 18.4K
- PSTX 539.2K
- Earning Date
- LSAK 11-06-2024
- PSTX 11-07-2024
- Dividend Yield
- LSAK N/A
- PSTX N/A
- EPS Growth
- LSAK N/A
- PSTX N/A
- EPS
- LSAK N/A
- PSTX N/A
- Revenue
- LSAK $564,222,000.00
- PSTX $88,462,000.00
- Revenue This Year
- LSAK $6.62
- PSTX $36.53
- Revenue Next Year
- LSAK $7.87
- PSTX N/A
- P/E Ratio
- LSAK N/A
- PSTX N/A
- Revenue Growth
- LSAK 6.87
- PSTX N/A
- 52 Week Low
- LSAK $3.00
- PSTX $1.83
- 52 Week High
- LSAK $5.33
- PSTX $4.27
- Technical
- Relative Strength Index (RSI)
- LSAK 58.96
- PSTX 38.80
- Support Level
- LSAK $4.99
- PSTX $2.41
- Resistance Level
- LSAK $5.08
- PSTX $2.61
- Average True Range (ATR)
- LSAK 0.11
- PSTX 0.11
- MACD
- LSAK 0.01
- PSTX -0.00
- Stochastic Oscillator
- LSAK 100.00
- PSTX 32.14
About PSTX Poseida Therapeutics Inc.
Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.